Cargando…

hsa-miR-485-5p reverses epithelial to mesenchymal transition and promotes cisplatin-induced cell death by targeting PAK1 in oral tongue squamous cell carcinoma

Oral squamous cell carcinoma (OSCC) is currently a highly prevalent disease worldwide. Cisplatin (CDDP) is widely used for the chemotherapy of OSCC. Yet, the molecular mechanisms responsible for cisplatin resistance have not been fully elucidated. In this study, we showed that overexpression of p21...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Xiu-Juan, He, Chang-Li, Sun, Ting, Duan, Xue-Jing, Sun, Yi, Xiong, Shi-Jiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466395/ https://www.ncbi.nlm.nih.gov/pubmed/28535002 http://dx.doi.org/10.3892/ijmm.2017.2992

Ejemplares similares

MicroRNA-485-5p suppresses the progression of esophageal squamous cell carcinoma by targeting flotillin-1 and inhibits the epithelial-mesenchymal transition
por: Zhao, Riyang, et al.
Publicado: (2021)

FNDC3B promotes epithelial-mesenchymal transition in tongue squamous cell carcinoma cells in a hypoxic microenvironment
por: Zhong, Zhaoming, et al.
Publicado: (2021)

Sox2 promotes tumor aggressiveness and epithelial-mesenchymal transition in tongue squamous cell carcinoma
por: Liu, Xingguang, et al.
Publicado: (2018)

Exosomal miR-485-3p derived from pancreatic ductal epithelial cells inhibits pancreatic cancer metastasis through targeting PAK1
por: Li, Mingzhe, et al.
Publicado: (2022)

LncRNA NKILA Promotes Epithelial-Mesenchymal Transition of Liver Cancer Cells by Targeting miR-485-5p
por: Wang, Yuxu, et al.
Publicado: (2021)

LINC01224 Exhibits Cancer-Promoting Activity in Epithelial Ovarian Cancer Through microRNA-485-5p-Mediated PAK4 Upregulation
por: Xing, Shujian, et al.
Publicado: (2020)

Vimentin is a potential prognostic factor for tongue squamous cell carcinoma among five epithelial–mesenchymal transition-related proteins
por: Liu, Pei-Feng, et al.
Publicado: (2017)

Deregulation of Hexokinase II Is Associated with Glycolysis, Autophagy, and the Epithelial-Mesenchymal Transition in Tongue Squamous Cell Carcinoma under Hypoxia
por: Chen, Guanhui, et al.
Publicado: (2018)

Activation of adrenergic receptor β2 promotes tumor progression and epithelial mesenchymal transition in tongue squamous cell carcinoma
por: Liu, Haichao, et al.
Publicado: (2018)

miR-27b Suppresses Tongue Squamous Cell Carcinoma Epithelial–Mesenchymal Transition by Targeting ITGA5
por: Li, Tao, et al.
Publicado: (2020)

LINC01224 Exhibits Cancer-Promoting Activity in Epithelial Ovarian Cancer Through microRNA-485-5p-Mediated PAK4 Upregulation [Retraction]
Publicado: (2021)

GATA1 induces epithelial-mesenchymal transition in breast cancer cells through PAK5 oncogenic signaling
por: Li, Yang, et al.
Publicado: (2015)

Lnc-PICSAR contributes to cisplatin resistance by miR-485-5p/REV3L axis in cutaneous squamous cell carcinoma
por: Wang, Dan, et al.
Publicado: (2020)

Group I Paks are essential for epithelial- mesenchymal transition in an Apc-driven model of colorectal cancer
por: Chow, H. Y., et al.
Publicado: (2018)

JBP485 promotes corneal epithelial wound healing
por: Nagata, Maho, et al.
Publicado: (2015)

MiR-26a/miR-26b represses tongue squamous cell carcinoma progression by targeting PAK1
por: Wei, Zhenxing, et al.
Publicado: (2020)

Long non-coding RNA NKILA inhibits migration and invasion of tongue squamous cell carcinoma cells via suppressing epithelial-mesenchymal transition
por: Huang, Wei, et al.
Publicado: (2016)

Molecular mechanism underlying epithelial‐mesenchymal transformation and cisplatin resistance in esophageal squamous cell carcinoma
por: Song, Kewei, et al.
Publicado: (2023)

Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma
por: Krisanaprakornkit, Suttichai, et al.
Publicado: (2012)

Plumbagin suppresses epithelial to mesenchymal transition and stemness via inhibiting Nrf2-mediated signaling pathway in human tongue squamous cell carcinoma cells
por: Pan, Shu-Ting, et al.
Publicado: (2015)

Cultivation of Head and Neck Squamous Cell Carcinoma Cells with Wound Fluid Leads to Cisplatin Resistance via Epithelial-Mesenchymal Transition Induction
por: Meyer, Till Jasper, et al.
Publicado: (2021)

Cisplatin resistance in gastric cancer cells is involved with GPR30‐mediated epithelial‐mesenchymal transition
por: Wang, Xiaofeng, et al.
Publicado: (2020)

Long non-coding RNA LINC01296 promotes progression of oral squamous cell carcinoma through activating the MAPK/ERK signaling pathway via the miR-485-5p/PAK4 axis
por: Zhang, Shuangyue, et al.
Publicado: (2019)

Metformin reverses bFGF-induced epithelial-mesenchymal transition in HCC cells
por: Chengye, Wang, et al.
Publicado: (2017)

Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance
por: Ashrafizadeh, Milad, et al.
Publicado: (2020)

Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition
por: Huang, Dongsheng, et al.
Publicado: (2016)

PLAU Promotes Cell Proliferation and Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma
por: Chen, Guangjin, et al.
Publicado: (2021)

Hsa_circ_0057105 modulates a balance of epithelial‐mesenchymal transition and ferroptosis vulnerability in renal cell carcinoma
por: Cen, Junjie, et al.
Publicado: (2023)

Numb inhibits cell proliferation, invasion, and epithelial–mesenchymal transition through PAK1/β-catenin signaling pathway in ovarian cancer
por: Liang, Jiabin, et al.
Publicado: (2019)

Epithelial-to-Mesenchymal Transition in the Development and Progression of Adenocarcinoma and Squamous Cell Carcinoma of the Lung
por: Prudkin, Ludmila, et al.
Publicado: (2009)

Epithelial-to-Mesenchymal Transition and Neoangiogenesis in Laryngeal Squamous Cell Carcinoma
por: Franz, Leonardo, et al.
Publicado: (2021)

CircLMTK2 Silencing Attenuates Gemcitabine Resistance in Pancreatic Cancer by Sponging miR-485-5p and to Target PAK1
por: Lu, Yeting, et al.
Publicado: (2022)

Norcantharidin reverses cisplatin resistance and inhibits the epithelial mesenchymal transition of human non-small lung cancer cells by regulating the YAP pathway
por: Jin, Dan, et al.
Publicado: (2018)

Norcantharidin reverses cisplatin resistance and inhibits the epithelial mesenchymal transition of human non-small lung cancer cells by regulating the YAP pathway
por: Jin, Dan, et al.
Publicado: (2021)

Doxycycline reverses epithelial-to-mesenchymal transition and suppresses the proliferation and metastasis of lung cancer cells
por: Qin, Yuan, et al.
Publicado: (2015)

Bmi1 Essentially Mediates Podocalyxin-Enhanced Cisplatin Chemoresistance in Oral Tongue Squamous Cell Carcinoma
por: Zhou, Yueying, et al.
Publicado: (2015)

Plumbagin Enhances the Anticancer Efficacy of Cisplatin by Increasing Intracellular ROS in Human Tongue Squamous Cell Carcinoma
por: Xue, Danfeng, et al.
Publicado: (2020)

Symphonie no. 5 D485 Symphonie no. 6 D485 /
por: Schubert, Franz, 1797-1828
Publicado: (1988)

Resveratrol Inhibits Cisplatin-Induced Epithelial-to-Mesenchymal Transition in Ovarian Cancer Cell Lines
por: Baribeau, Sébastien, et al.
Publicado: (2014)

lncRNA MALAT1 potentiates the progression of tongue squamous cell carcinoma through regulating miR-140-5p-PAK1 pathway
por: Zhu, Minhui, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m0069hed9cpr2v5o5ua3sb0kph